Literature DB >> 4026978

Clinical conditions in alcoholics during long-term abstinence: a descriptive, longitudinal treatment study.

D Mossberg, P Liljeberg, S Borg.   

Abstract

After inpatient treatment for acute withdrawal during 1-2 weeks, twelve male alcoholics were treated as outpatients and received disulfiram per os. clinical ratings using a scale with 14 items were performed three times a week during six months. After acute withdrawal had ceased, all patients had positive ratings for anxiety, sleeping problems and autonomic disturbances lasting for 4-8 weeks. They also scored for depressive symptoms, concentration difficulties and failing memory during this period. The following 8-12 weeks all patients but one had periods of mood changes with a duration of 1-3 weeks. During periods with low mood changes several other symptoms appeared, while other psychiatric symptoms were absent during periods with elevated mood. All relapses occurred in connection with periods of mood changes. To conclude, this rating scale made it possible to identify a protracted subacute withdrawal phase and phases characterized by changes of mood, depressive-astenic as well as hyperactive, during long-term abstinence. These clinical phases are suggested to be of importance for clinical treatment and research.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026978     DOI: 10.1016/0741-8329(85)90133-8

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  14 in total

1.  Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.

Authors:  Karen L Skjei; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-24       Impact factor: 4.530

2.  Stress enhancement of craving during sobriety: a risk for relapse.

Authors:  George R Breese; Kathleen Chu; Christopher V Dayas; Douglas Funk; Darin J Knapp; George F Koob; Dzung Anh Lê; Laura E O'Dell; David H Overstreet; Amanda J Roberts; Rajita Sinha; Glenn R Valdez; Friedbert Weiss
Journal:  Alcohol Clin Exp Res       Date:  2005-02       Impact factor: 3.455

3.  Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout.

Authors:  Kathleen Chu; George F Koob; Maury Cole; Eric P Zorrilla; Amanda J Roberts
Journal:  Pharmacol Biochem Behav       Date:  2007-04-03       Impact factor: 3.533

Review 4.  Corticotropin releasing factor: a key role in the neurobiology of addiction.

Authors:  Eric P Zorrilla; Marian L Logrip; George F Koob
Journal:  Front Neuroendocrinol       Date:  2014-01-20       Impact factor: 8.606

5.  The risk for persistent adult alcohol and nicotine dependence: the role of childhood maltreatment.

Authors:  Jennifer C Elliott; Malka Stohl; Melanie M Wall; Katherine M Keyes; Renee D Goodwin; Andrew E Skodol; Robert F Krueger; Bridget F Grant; Deborah S Hasin
Journal:  Addiction       Date:  2014-02-16       Impact factor: 6.526

6.  Prolonged chronic ethanol exposure alters neuropeptide Y and corticotropin-releasing factor levels in the brain of adult Wistar rats.

Authors:  José R Criado; Tianmin Liu; Cindy L Ehlers; Aleksander A Mathé
Journal:  Pharmacol Biochem Behav       Date:  2011-04-17       Impact factor: 3.533

Review 7.  Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.

Authors:  Eric P Zorrilla; Markus Heilig; Harriet de Wit; Yavin Shaham
Journal:  Drug Alcohol Depend       Date:  2013-01-05       Impact factor: 4.492

Review 8.  Predicting treatment outcome in stimulant dependence.

Authors:  Martina Reske; Martin P Paulus
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 9.  Operant alcohol self-administration in dependent rats: focus on the vapor model.

Authors:  Leandro F Vendruscolo; Amanda J Roberts
Journal:  Alcohol       Date:  2013-11-01       Impact factor: 2.405

Review 10.  Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.

Authors:  Marisa Roberto; Samantha R Spierling; Dean Kirson; Eric P Zorrilla
Journal:  Int Rev Neurobiol       Date:  2017-08-07       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.